Quantcast

Latest Mast Therapeutics Inc. Stories

2015-04-21 08:35:31

On Track for Top-Line Data in Q1 2016 SAN DIEGO, April 21, 2015 /PRNewswire/ -- Mast Therapeutics, Inc.

2015-03-24 08:33:29

SAN DIEGO, March 24, 2015 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX), a clinical-stage biopharmaceutical

2015-03-02 08:33:55

- Study reproduced earlier findings that a single, 2-hour intravenous administration of vepoloxamer resulted in robust improvements in key parameters of heart function that persisted for up to 2 weeks

2015-02-24 08:35:03

SAN DIEGO, Feb. 24, 2015 /PRNewswire/ -- Mast Therapeutics, Inc.

2015-02-11 08:31:43

- Vepoloxamer alone and in combination with tPA improved neurologic function and reduced brain tissue loss compared to tPA alone and saline controls SAN DIEGO, Feb.

2015-02-04 08:29:50

Mayo Clinic & University of Pittsburgh have initiated patient dosing in AIR001 studies SAN DIEGO, Feb.

2015-02-03 08:33:05

SAN DIEGO, Feb. 3, 2015 /PRNewswire/ -- Mast Therapeutics, Inc.

2015-01-24 20:20:33

SAN DIEGO, Jan.

2015-01-07 08:30:02

SAN DIEGO, Jan. 7, 2015 /PRNewswire/ -- Mast Therapeutics, Inc.

2015-01-05 16:26:02

-- EPIC Study More Than One-Third Complete SAN DIEGO, Jan.


Word of the Day
dipsas
  • A serpent whose bite was fabled to produce intense thirst.
The word 'dipsas' comes from a Greek word meaning 'thirst'.